Register Today for the 15th Annual AACI CRI Meeting


Registration is open for the 15th Annual AACI Clinical Research Innovation (CRI) Meeting, which will be held June 26-28 at the Loews Chicago O'Hare Hotel in Rosemont, IL. This year’s programming for the CRI meeting, "Taking Innovations in Clinical Research From Abstract to Reality," aims to stimulate cancer center interactions and maximize resources by creating opportunities for peer-to-peer networking and collaboration.

Submit an Abstract 

The AACI CRI Steering Committee is currently soliciting abstracts for the 15th Annual AACI CRI Meeting. The purpose of the abstracts is to inform meeting attendees about clinical trials office challenges and solutions implemented at AACI cancer centers. The deadline to submit completed abstracts is 5:00 pm Pacific time on Monday, March 13.

Promote Your Cancer Center With a Meeting Program Ad

AACI invites you to promote your cancer center by purchasing an ad in the 15th Annual AACI CRI Meeting program book. Your cancer center’s program ad may highlight a conference or a new initiative, or celebrate the success of the center’s clinical trials office. Cancer centers may include links to their website and any upcoming events for the digital program book. (Links will not appear in the printed program book.)

Artwork should be submitted to Communications and External Relations Manager Emily Stimmel by Wednesday, May 3 for inclusion in the event program. Please direct any questions about ad pricing and additional support opportunities to Development Coordinator Shelly Pocratsky.

15th Annual AACI CRI Meeting Program Ad Specs

Full page (4.5” W x 7.5” H): $2,500
Half page (4.5” W x 3.625” H): $1,500

Ads should be submitted as high resolution (300 dpi) PDF files. Other acceptable formats are TIFF, EPS, and JPEG. If submitting EPS files, please make sure all fonts are converted to outlines. CMYK color is preferred. All images used, such as logos and photography, must be high resolution (300 dpi) and free of copyright infringements.